{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "03", "@year": "2024", "@timestamp": "2024-11-03T01:44:52.000052-05:00", "@month": "11"}, "ait:date-sort": {"@day": "14", "@year": "2015", "@month": "12"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "@afid": "60012718", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Clinical Tropical Medicine"}, {"$": "Faculty of Tropical Medicine"}, {"$": "Mahidol University"}], "affiliation-id": {"@afid": "60012718", "@dptid": "103674644"}, "@dptid": "103674644"}, "author": [{"ce:given-name": "Aung Myint", "preferred-name": {"ce:given-name": "Aung Myint", "ce:initials": "A.M.", "ce:surname": "Thu", "ce:indexed-name": "Thu A.M."}, "@seq": "1", "ce:initials": "A.M.", "@_fa": "true", "@type": "auth", "ce:surname": "Thu", "@auid": "57003282800", "ce:indexed-name": "Thu A.M."}, {"ce:given-name": "Kittiyod", "preferred-name": {"ce:given-name": "Kittiyod", "ce:initials": "K.", "ce:surname": "Poovorawan", "ce:indexed-name": "Poovorawan K."}, "@seq": "2", "ce:initials": "K.", "@date-locked": "2020-03-11T01:54:47.146", "@_fa": "true", "@type": "auth", "ce:surname": "Poovorawan", "@auid": "11141160200", "ce:indexed-name": "Poovorawan K."}, {"ce:given-name": "Chatporn", "preferred-name": {"ce:given-name": "Chatporn", "ce:initials": "C.", "ce:surname": "Kittitrakul", "ce:indexed-name": "Kittitrakul C."}, "@seq": "3", "ce:initials": "C.", "@_fa": "true", "@type": "auth", "ce:surname": "Kittitrakul", "@auid": "6504568189", "ce:indexed-name": "Kittitrakul C."}, {"ce:given-name": "Apichart", "preferred-name": {"ce:given-name": "Apichart", "ce:initials": "A.", "ce:surname": "Nontprasert", "ce:indexed-name": "Nontprasert A."}, "@seq": "4", "ce:initials": "A.", "@date-locked": "2019-01-02T06:51:59.471", "@_fa": "true", "@type": "auth", "ce:surname": "Nontprasert", "@auid": "6602437920", "ce:indexed-name": "Nontprasert A."}, {"ce:given-name": "Natthida", "preferred-name": {"ce:given-name": "Natthida", "ce:initials": "N.", "ce:surname": "Sriboonvorakul", "ce:indexed-name": "Sriboonvorakul N."}, "@seq": "5", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:surname": "Sriboonvorakul", "@auid": "55919328500", "ce:indexed-name": "Sriboonvorakul N."}, {"ce:given-name": "Weerapong", "preferred-name": {"ce:given-name": "Weerapong", "ce:initials": "W.", "ce:surname": "Phumratanaprapin", "ce:indexed-name": "Phumratanaprapin W."}, "@seq": "6", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:surname": "Phumratanaprapin", "@auid": "6602291191", "ce:indexed-name": "Phumratanaprapin W."}, {"ce:given-name": "Wattana", "preferred-name": {"ce:given-name": "Wattana", "ce:initials": "W.", "ce:surname": "Leowattana", "ce:indexed-name": "Leowattana W."}, "@seq": "8", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:surname": "Leowattana", "@auid": "7006285042", "ce:indexed-name": "Leowattana W."}, {"ce:given-name": "Polrat", "preferred-name": {"ce:given-name": "Polrat", "ce:initials": "P.", "ce:surname": "Wilairatana", "ce:indexed-name": "Wilairatana P."}, "@seq": "9", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Wilairatana", "@auid": "7006979896", "ce:indexed-name": "Wilairatana P."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Research Unit of Hepatitis and Liver Cancer"}, {"$": "Department of Biochemistry"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "112978483"}, "@dptid": "112978483"}, "author": [{"ce:given-name": "Pisit", "preferred-name": {"ce:given-name": "Pisit", "ce:initials": "P.", "ce:surname": "Tangkijvanich", "ce:indexed-name": "Tangkijvanich P."}, "@seq": "7", "ce:initials": "P.", "@date-locked": "2022-01-31T12:27:27.966", "@_fa": "true", "@type": "auth", "ce:surname": "Tangkijvanich", "@auid": "7003646635", "ce:indexed-name": "Tangkijvanich P."}]}], "citation-title": "Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand", "abstracts": "\u00a9 2015 Thu et al.Background: There is increasing concern about the potential for nephrotoxicity in patients with chronic hepatitis B (CHB) treated long-term with nucleotide analogs. Methods: We examined renal dysfunction and its associated risk factors in patients with CHB treated with antiviral regimens containing either nucleosides or nucleotide analogs. We undertook a retrospective cohort study from 2006 to 2014 at the Hospital for Tropical Diseases, Bangkok, Thailand, and analyzed the data of 102 patients with a median follow-up time of 44.5 months (range 4-101 months). Results: Seventy-three patients were treated with an antiviral regime containing a nucleoside analog, and 29 with a regime containing a nucleotide analog. Abnormally elevated serum creatinine concentration was observed in 12 patients (11.8 %) after 8 years of treatment. Thirty one percent of patients treated with nucleotide analogs had elevated serum creatinine levels and three of these patients (10.3 %) developed nephrotoxicity. In contrast, serum creatinine concentrations were elevated in three of the 73 patients treated with a nucleoside analog (4.1 %), and none developed nephrotoxicity. The incidence of renal dysfunction by the nucleotide analog regimen was cumulative, with 11.1, 21.0, 26.5 and 47.6 % of patients affected after 2, 4, 6 and 8 years, respectively. Univariate and multivariate analysis indicated that a nucleotide analog-based regimen significantly predicted renal dysfunction (odds ratio 10.5, 95 % confidence intervals 2.6-42.4, P <0.001). Conclusion: The long-term use of nucleotide analogs increased the risk of nephrotoxicity in patients with CHB. Thus, the regular assessment of renal function is recommended for all patients with CHB, particularly those treated with a nucleotide analog.", "correspondence": {"affiliation": {"country": "Thailand", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Clinical Tropical Medicine"}, {"$": "Faculty of Tropical Medicine"}, {"$": "Mahidol University"}]}, "person": {"ce:given-name": "Kittiyod", "ce:initials": "K.", "ce:surname": "Poovorawan", "ce:indexed-name": "Poovorawan K."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Antiviral agents", "@xml:lang": "eng"}, {"$": "Chronic hepatitis B", "@xml:lang": "eng"}, {"$": "Nephrotoxicity", "@xml:lang": "eng"}, {"$": "Nucleoside", "@xml:lang": "eng"}, {"$": "Nucleotide", "@xml:lang": "eng"}, {"$": "Thailand", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://www.biomedcentral.com/bmcpharmacoltoxicol/", "@type": "email"}}, "translated-sourcetitle": {"$": "BMC Pharmacology and Toxicology", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "16", "@issue": "1"}}, "@type": "j", "sourcetitle": "BMC Pharmacology and Toxicology", "publicationdate": {"month": "12", "year": "2015", "date-text": "December 14, 2015", "day": "14"}, "sourcetitle-abbrev": "BMC Pharmacol. Toxicol.", "@country": "gbr", "issn": [{"$": "20506511", "@type": "electronic"}, {"$": "20506511", "@type": "print"}], "publicationyear": {"@first": "2015"}, "publisher": {"publishername": "BioMed Central Ltd.", "ce:e-address": {"$": "info@biomedcentral.com", "@type": "email"}}, "article-number": "38", "@srcid": "21100218055"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "28", "classification-description": "Urology and Nephrology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "38", "classification-description": "Adverse Reactions Titles"}, {"classification-code": "4", "classification-description": "Microbiology: Bacteriology, Mycology, Parasitology and Virology"}, {"classification-code": "48", "classification-description": "Gastroenterology"}]}, {"@type": "ASJC", "classification": [{"$": "3004"}, {"$": "2736"}]}, {"@type": "SUBJABBR", "classification": [{"$": "PHAR"}, {"$": "MEDI"}]}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "106941-25-7", "chemical-name": "adefovir"}, {"cas-registry-number": [{"$": "19230-81-0"}, {"$": "60-27-5"}], "chemical-name": "creatinine"}, {"cas-registry-number": [{"$": "142217-69-4"}, {"$": "209216-23-9"}], "chemical-name": "entecavir"}, {"cas-registry-number": [{"$": "134678-17-4"}, {"$": "134680-32-3"}], "chemical-name": "lamivudine"}, {"cas-registry-number": "3424-98-4", "chemical-name": "telbivudine"}, {"cas-registry-number": [{"$": "147127-19-3"}, {"$": "147127-20-6"}], "chemical-name": "tenofovir"}, {"cas-registry-number": [{"$": "22177-51-1"}, {"$": "2922-28-3"}, {"$": "73-24-5"}], "chemical-name": "adenine"}, {"cas-registry-number": [{"$": "69257-39-2"}, {"$": "73-40-5"}], "chemical-name": "guanine"}, {"cas-registry-number": "50-89-5", "chemical-name": "thymidine"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "adefovir"}, {"chemical-name": "Adenine"}, {"chemical-name": "Antiviral Agents"}, {"chemical-name": "Creatinine"}, {"chemical-name": "entecavir"}, {"chemical-name": "Guanine"}, {"chemical-name": "Lamivudine"}, {"chemical-name": "Organophosphonates"}, {"chemical-name": "telbivudine"}, {"chemical-name": "Tenofovir"}, {"chemical-name": "Thymidine"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2016 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}, {"$": "MEDL"}], "history": {"date-created": {"@day": "07", "@year": "2016", "@timestamp": "BST 05:51:33", "@month": "01"}}, "itemidlist": {"itemid": [{"$": "607270397", "@idtype": "PUI"}, {"$": "643107002", "@idtype": "CAR-ID"}, {"$": "20151032399", "@idtype": "EMBASE"}, {"$": "2015015546", "@idtype": "RMC"}, {"$": "84952877007", "@idtype": "SCP"}, {"$": "84952877007", "@idtype": "SGR"}, {"$": "611178027", "@idtype": "PUIsecondary"}, {"$": "26651337", "@idtype": "MEDL"}], "ce:doi": "10.1186/s40360-015-0037-6"}}, "tail": {"bibliography": {"@refcount": "26", "reference": [{"ref-fulltext": "Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med. 2004;350(11):1118-29.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Hepatitis B virus infection--natural history and clinical consequences"}, "refd-itemidlist": {"itemid": {"$": "1542316127", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "350", "@issue": "11"}, "pagerange": {"@first": "1118", "@last": "1129"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Ganem", "ce:indexed-name": "Ganem D."}, {"@seq": "2", "ce:initials": "A.M.", "@_fa": "true", "ce:surname": "Prince", "ce:indexed-name": "Prince A.M."}]}, "ref-sourcetitle": "N Engl J Med"}}, {"ref-fulltext": "Khungar V, Han SH. A systematic review of side effects of nucleoside and nucleotide drugs used for treatment of chronic hepatitis B. Curr Hepat Rep. 2010;9(2):75-90.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "A systematic review of side effects of nucleoside and nucleotide drugs used for treatment of chronic hepatitis B"}, "refd-itemidlist": {"itemid": {"$": "77955985167", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9", "@issue": "2"}, "pagerange": {"@first": "75", "@last": "90"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Khungar", "ce:indexed-name": "Khungar V."}, {"@seq": "2", "ce:initials": "S.H.", "@_fa": "true", "ce:surname": "Han", "ce:indexed-name": "Han S.H."}]}, "ref-sourcetitle": "Curr Hepat Rep"}}, {"ref-fulltext": "Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661-2.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Chronic hepatitis B: update 2009"}, "refd-itemidlist": {"itemid": {"$": "70349240414", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "50", "@issue": "3"}, "pagerange": {"@first": "661", "@last": "662"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.S.", "@_fa": "true", "ce:surname": "Lok", "ce:indexed-name": "Lok A.S."}, {"@seq": "2", "ce:initials": "B.J.", "@_fa": "true", "ce:surname": "McMahon", "ce:indexed-name": "McMahon B.J."}]}, "ref-sourcetitle": "Hepatology"}}, {"ref-fulltext": "Hadziyannis SJ. New developments in the treatment of chronic hepatitis B. Expert Opin Biol Ther. 2006;6(9):913-21.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "New developments in the treatment of chronic hepatitis B"}, "refd-itemidlist": {"itemid": {"$": "33749054748", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "6", "@issue": "9"}, "pagerange": {"@first": "913", "@last": "921"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Hadziyannis", "ce:indexed-name": "Hadziyannis S.J."}]}, "ref-sourcetitle": "Expert Opin Biol Ther"}}, {"ref-fulltext": "Hwang JA, Kim KB, Yang MJ, Lim SG, Hwang JC, Cheong JY, et al. Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients. Clin Mol Hepatol. 2015;21(2):131-40.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Impact of prior lamivudine use on the antiviral efficacy and development of resistance to entecavir in chronic hepatitis B patients"}, "refd-itemidlist": {"itemid": {"$": "85050578006", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "21", "@issue": "2"}, "pagerange": {"@first": "131", "@last": "140"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Hwang", "ce:indexed-name": "Hwang J.A."}, {"@seq": "2", "ce:initials": "K.B.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim K.B."}, {"@seq": "3", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Yang", "ce:indexed-name": "Yang M.J."}, {"@seq": "4", "ce:initials": "S.G.", "@_fa": "true", "ce:surname": "Lim", "ce:indexed-name": "Lim S.G."}, {"@seq": "5", "ce:initials": "J.C.", "@_fa": "true", "ce:surname": "Hwang", "ce:indexed-name": "Hwang J.C."}, {"@seq": "6", "ce:initials": "J.Y.", "@_fa": "true", "ce:surname": "Cheong", "ce:indexed-name": "Cheong J.Y."}, {"@seq": "7", "ce:initials": "S.W.", "@_fa": "true", "ce:surname": "Cho", "ce:indexed-name": "Cho S.W."}, {"@seq": "8", "ce:initials": "S.S.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim S.S."}]}, "ref-sourcetitle": "Clin Mol Hepatol"}}, {"ref-fulltext": "Lai CL, Yuen MF. The saga of entecavir. Hepatol Int. 2009;3(3):421-4.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "The saga of entecavir"}, "refd-itemidlist": {"itemid": {"$": "68949161844", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "3", "@issue": "3"}, "pagerange": {"@first": "421", "@last": "424"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.L.", "@_fa": "true", "ce:surname": "Lai", "ce:indexed-name": "Lai C.L."}, {"@seq": "2", "ce:initials": "M.F.", "@_fa": "true", "ce:surname": "Yuen", "ce:indexed-name": "Yuen M.F."}]}, "ref-sourcetitle": "Hepatol Int"}}, {"ref-fulltext": "Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med. 2003;348(9):808-16.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B"}, "refd-itemidlist": {"itemid": {"$": "0037468421", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "348", "@issue": "9"}, "pagerange": {"@first": "808", "@last": "816"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Marcellin", "ce:indexed-name": "Marcellin P."}, {"@seq": "2", "ce:initials": "T.T.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang T.T."}, {"@seq": "3", "ce:initials": "S.G.", "@_fa": "true", "ce:surname": "Lim", "ce:indexed-name": "Lim S.G."}, {"@seq": "4", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Tong", "ce:indexed-name": "Tong M.J."}, {"@seq": "5", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Sievert", "ce:indexed-name": "Sievert W."}, {"@seq": "6", "ce:initials": "M.L.", "@_fa": "true", "ce:surname": "Shiffman", "ce:indexed-name": "Shiffman M.L."}, {"@seq": "7", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Jeffers", "ce:indexed-name": "Jeffers L."}, {"@seq": "8", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Goodman", "ce:indexed-name": "Goodman Z."}, {"@seq": "9", "ce:initials": "M.S.", "@_fa": "true", "ce:surname": "Wulfsohn", "ce:indexed-name": "Wulfsohn M.S."}, {"@seq": "10", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Xiong", "ce:indexed-name": "Xiong S."}], "et-al": null}, "ref-sourcetitle": "N Engl J Med"}}, {"ref-fulltext": "Jonas MM, Kelly D, Pollack H, Mizerski J, Sorbel J, Frederick D, et al. Safety, efficacy, and pharmacokinetics of Adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B. Hepatology. 2008;47(6):1863-71.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Safety, efficacy, and pharmacokinetics of Adefovir dipivoxil in children and adolescents (age 2 to <18 years) with chronic hepatitis B"}, "refd-itemidlist": {"itemid": {"$": "46249118136", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "47", "@issue": "6"}, "pagerange": {"@first": "1863", "@last": "1871"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Jonas", "ce:indexed-name": "Jonas M.M."}, {"@seq": "2", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Kelly", "ce:indexed-name": "Kelly D."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Pollack", "ce:indexed-name": "Pollack H."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Mizerski", "ce:indexed-name": "Mizerski J."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Sorbel", "ce:indexed-name": "Sorbel J."}, {"@seq": "6", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Frederick", "ce:indexed-name": "Frederick D."}, {"@seq": "7", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Mondou", "ce:indexed-name": "Mondou E."}, {"@seq": "8", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Rousseau", "ce:indexed-name": "Rousseau F."}, {"@seq": "9", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Sokal", "ce:indexed-name": "Sokal E."}]}, "ref-sourcetitle": "Hepatology"}}, {"ref-fulltext": "Izzedine H, Hulot JS, Launay-Vacher V, Marcellini P, Hadziyannis SJ, Currie G, et al. Renal safety of Adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies. Kidney Int. 2004;66(3):1153-8.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Renal safety of Adefovir dipivoxil in patients with chronic hepatitis B: two double-blind, randomized, placebo-controlled studies"}, "refd-itemidlist": {"itemid": {"$": "4344623455", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "66", "@issue": "3"}, "pagerange": {"@first": "1153", "@last": "1158"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Izzedine", "ce:indexed-name": "Izzedine H."}, {"@seq": "2", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Hulot", "ce:indexed-name": "Hulot J.S."}, {"@seq": "3", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Launay-Vacher", "ce:indexed-name": "Launay-Vacher V."}, {"@seq": "4", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Marcellini", "ce:indexed-name": "Marcellini P."}, {"@seq": "5", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Hadziyannis", "ce:indexed-name": "Hadziyannis S.J."}, {"@seq": "6", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Currie", "ce:indexed-name": "Currie G."}, {"@seq": "7", "ce:initials": "C.L.", "@_fa": "true", "ce:surname": "Brosgart", "ce:indexed-name": "Brosgart C.L."}, {"@seq": "8", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Westland", "ce:indexed-name": "Westland C."}, {"@seq": "9", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Arterbrun", "ce:indexed-name": "Arterbrun S."}, {"@seq": "10", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Deray", "ce:indexed-name": "Deray G."}]}, "ref-sourcetitle": "Kidney Int"}}, {"ref-fulltext": "Lim SG, Marcellin P, Tassopoulos N, Hadziyannis S, Chang TT, Tong M, et al. Clinical trial: effects of Adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B. Aliment Pharmacol Ther. 2007;26(10):1419-28.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Clinical trial: effects of Adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B"}, "refd-itemidlist": {"itemid": {"$": "35748964135", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "26", "@issue": "10"}, "pagerange": {"@first": "1419", "@last": "1428"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.G.", "@_fa": "true", "ce:surname": "Lim", "ce:indexed-name": "Lim S.G."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Marcellin", "ce:indexed-name": "Marcellin P."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Tassopoulos", "ce:indexed-name": "Tassopoulos N."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Hadziyannis", "ce:indexed-name": "Hadziyannis S."}, {"@seq": "5", "ce:initials": "T.T.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang T.T."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Tong", "ce:indexed-name": "Tong M."}, {"@seq": "7", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Sievert", "ce:indexed-name": "Sievert W."}, {"@seq": "8", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Hu", "ce:indexed-name": "Hu P."}, {"@seq": "9", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Arterburn", "ce:indexed-name": "Arterburn S."}, {"@seq": "10", "ce:initials": "C.L.", "@_fa": "true", "ce:surname": "Brosgart", "ce:indexed-name": "Brosgart C.L."}]}, "ref-sourcetitle": "Aliment Pharmacol Ther"}}, {"ref-fulltext": "Hartono JL, Aung MO, Dan YY, Gowans M, Lim K, Lee YM, et al. Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B. Aliment Pharmacol Ther. 2013;37(7):710-9.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B"}, "refd-itemidlist": {"itemid": {"$": "84874661218", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "37", "@issue": "7"}, "pagerange": {"@first": "710", "@last": "719"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Hartono", "ce:indexed-name": "Hartono J.L."}, {"@seq": "2", "ce:initials": "M.O.", "@_fa": "true", "ce:surname": "Aung", "ce:indexed-name": "Aung M.O."}, {"@seq": "3", "ce:initials": "Y.Y.", "@_fa": "true", "ce:surname": "Dan", "ce:indexed-name": "Dan Y.Y."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Gowans", "ce:indexed-name": "Gowans M."}, {"@seq": "5", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Lim", "ce:indexed-name": "Lim K."}, {"@seq": "6", "ce:initials": "Y.M.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee Y.M."}, {"@seq": "7", "ce:initials": "G.H.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee G.H."}, {"@seq": "8", "ce:initials": "H.C.", "@_fa": "true", "ce:surname": "Low", "ce:indexed-name": "Low H.C."}, {"@seq": "9", "ce:initials": "P.S.", "@_fa": "true", "ce:surname": "Tan", "ce:indexed-name": "Tan P.S."}, {"@seq": "10", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Thwin", "ce:indexed-name": "Thwin M.A."}], "et-al": null}, "ref-sourcetitle": "Aliment Pharmacol Ther"}}, {"ref-fulltext": "Lampertico P, Vigano M, Manenti E, Iavarone M, Sablon E, Colombo M. Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients. Gastroenterology. 2007;133(5):1445-51.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients"}, "refd-itemidlist": {"itemid": {"$": "35648982926", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "133", "@issue": "5"}, "pagerange": {"@first": "1445", "@last": "1451"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Lampertico", "ce:indexed-name": "Lampertico P."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Vigano", "ce:indexed-name": "Vigano M."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Manenti", "ce:indexed-name": "Manenti E."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Iavarone", "ce:indexed-name": "Iavarone M."}, {"@seq": "5", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Sablon", "ce:indexed-name": "Sablon E."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Colombo", "ce:indexed-name": "Colombo M."}]}, "ref-sourcetitle": "Gastroenterology"}}, {"ref-fulltext": "Tamori A, Enomoto M, Kobayashi S, Iwai S, Morikawa H, Sakaguchi H, et al. Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus. J Viral Hepat. 2010;17(2):123-9.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Add-on combination therapy with adefovir dipivoxil induces renal impairment in patients with lamivudine-refractory hepatitis B virus"}, "refd-itemidlist": {"itemid": {"$": "74049135616", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "17", "@issue": "2"}, "pagerange": {"@first": "123", "@last": "129"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Tamori", "ce:indexed-name": "Tamori A."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Enomoto", "ce:indexed-name": "Enomoto M."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Kobayashi", "ce:indexed-name": "Kobayashi S."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Iwai", "ce:indexed-name": "Iwai S."}, {"@seq": "5", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Morikawa", "ce:indexed-name": "Morikawa H."}, {"@seq": "6", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Sakaguchi", "ce:indexed-name": "Sakaguchi H."}, {"@seq": "7", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Habu", "ce:indexed-name": "Habu D."}, {"@seq": "8", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Shiomi", "ce:indexed-name": "Shiomi S."}, {"@seq": "9", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Imanishi", "ce:indexed-name": "Imanishi Y."}, {"@seq": "10", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Kawada", "ce:indexed-name": "Kawada N."}]}, "ref-sourcetitle": "J Viral Hepat"}}, {"ref-fulltext": "Heathcote EJ, Gane E, De Man R, Lee S, Flisiak R, Manns M, et al. A randomized, double-blind, comparison of tenofovir DF (TDF) versus adefovir dipivoxil (ADV) for the treatment of HBeAg-positive chronic hepatitis B (CHB). Hepatology. 2007;46:S861A.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "A randomized, double-blind, comparison of tenofovir DF (TDF) versus adefovir dipivoxil (ADV) for the treatment of HBeAg-positive chronic hepatitis B (CHB)"}, "refd-itemidlist": {"itemid": {"$": "39149122593", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "46"}, "pagerange": {"@first": "S861A"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.J.", "@_fa": "true", "ce:surname": "Heathcote", "ce:indexed-name": "Heathcote E.J."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Gane", "ce:indexed-name": "Gane E."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Man", "ce:indexed-name": "Man R."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee S."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Flisiak", "ce:indexed-name": "Flisiak R."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Manns", "ce:indexed-name": "Manns M."}], "et-al": null}, "ref-sourcetitle": "Hepatology"}}, {"ref-fulltext": "Baran B, Soyer OM, Ormeci AC, Gokturk S, Evirgen S, Bozbey HU, et al. Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B. Antimicrob Agents Chemother. 2013;57(4):1790-6.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Efficacy of tenofovir in patients with Lamivudine failure is not different from that in nucleoside/nucleotide analogue-naive patients with chronic hepatitis B"}, "refd-itemidlist": {"itemid": {"$": "84875189825", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "57", "@issue": "4"}, "pagerange": {"@first": "1790", "@last": "1796"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Baran", "ce:indexed-name": "Baran B."}, {"@seq": "2", "ce:initials": "O.M.", "@_fa": "true", "ce:surname": "Soyer", "ce:indexed-name": "Soyer O.M."}, {"@seq": "3", "ce:initials": "A.C.", "@_fa": "true", "ce:surname": "Ormeci", "ce:indexed-name": "Ormeci A.C."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Gokturk", "ce:indexed-name": "Gokturk S."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Evirgen", "ce:indexed-name": "Evirgen S."}, {"@seq": "6", "ce:initials": "H.U.", "@_fa": "true", "ce:surname": "Bozbey", "ce:indexed-name": "Bozbey H.U."}, {"@seq": "7", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Akyuz", "ce:indexed-name": "Akyuz F."}, {"@seq": "8", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Karaca", "ce:indexed-name": "Karaca C."}, {"@seq": "9", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Demir", "ce:indexed-name": "Demir K."}, {"@seq": "10", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Besisik", "ce:indexed-name": "Besisik F."}], "et-al": null}, "ref-sourcetitle": "Antimicrob Agents Chemother"}}, {"ref-fulltext": "Buti M, Tsai N, Petersen J, Flisiak R, Gurel S, Krastev Z, et al. Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection. Dig Dis Sci. 2015;60(5):1457-64.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Seven-year efficacy and safety of treatment with tenofovir disoproxil fumarate for chronic hepatitis B virus infection"}, "refd-itemidlist": {"itemid": {"$": "84939650468", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "60", "@issue": "5"}, "pagerange": {"@first": "1457", "@last": "1464"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Buti", "ce:indexed-name": "Buti M."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Tsai", "ce:indexed-name": "Tsai N."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Petersen", "ce:indexed-name": "Petersen J."}, {"@seq": "4", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Flisiak", "ce:indexed-name": "Flisiak R."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Gurel", "ce:indexed-name": "Gurel S."}, {"@seq": "6", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Krastev", "ce:indexed-name": "Krastev Z."}, {"@seq": "7", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Aguilar Schall", "ce:indexed-name": "Aguilar Schall R."}, {"@seq": "8", "ce:initials": "J.F.", "@_fa": "true", "ce:surname": "Flaherty", "ce:indexed-name": "Flaherty J.F."}, {"@seq": "9", "ce:initials": "E.B.", "@_fa": "true", "ce:surname": "Martins", "ce:indexed-name": "Martins E.B."}, {"@seq": "10", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Charuworn", "ce:indexed-name": "Charuworn P."}], "et-al": null}, "ref-sourcetitle": "Dig Dis Sci"}}, {"ref-fulltext": "Fernandez-Fernandez B, Montoya-Ferrer A, Sanz AB, Sanchez-Nino MD, Izquierdo MC, Poveda J, et al. Tenofovir nephrotoxicity: 2011 update. AIDS Res Treat. 2011;2011:354908.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Tenofovir nephrotoxicity: 2011 update"}, "refd-itemidlist": {"itemid": {"$": "84860524400", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2011"}, "pagerange": {"@first": "354908"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Fernandez-Fernandez", "ce:indexed-name": "Fernandez-Fernandez B."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Montoya-Ferrer", "ce:indexed-name": "Montoya-Ferrer A."}, {"@seq": "3", "ce:initials": "A.B.", "@_fa": "true", "ce:surname": "Sanz", "ce:indexed-name": "Sanz A.B."}, {"@seq": "4", "ce:initials": "M.D.", "@_fa": "true", "ce:surname": "Sanchez-Nino", "ce:indexed-name": "Sanchez-Nino M.D."}, {"@seq": "5", "ce:initials": "M.C.", "@_fa": "true", "ce:surname": "Izquierdo", "ce:indexed-name": "Izquierdo M.C."}, {"@seq": "6", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Poveda", "ce:indexed-name": "Poveda J."}, {"@seq": "7", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Sainz-Prestel", "ce:indexed-name": "Sainz-Prestel V."}, {"@seq": "8", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Ortiz-Martin", "ce:indexed-name": "Ortiz-Martin N."}, {"@seq": "9", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Parra-Rodriguez", "ce:indexed-name": "Parra-Rodriguez A."}, {"@seq": "10", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Selgas", "ce:indexed-name": "Selgas R."}], "et-al": null}, "ref-sourcetitle": "AIDS Res Treat"}}, {"ref-fulltext": "Rodriguez-Novoa S, Alvarez E, Labarga P, Soriano V. Renal toxicity associated with tenofovir use. Expert Opin Drug Saf. 2010;9(4):545-59.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Renal toxicity associated with tenofovir use"}, "refd-itemidlist": {"itemid": {"$": "77953770191", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9", "@issue": "4"}, "pagerange": {"@first": "545", "@last": "559"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Rodriguez-Novoa", "ce:indexed-name": "Rodriguez-Novoa S."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Alvarez", "ce:indexed-name": "Alvarez E."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Labarga", "ce:indexed-name": "Labarga P."}, {"@seq": "4", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Soriano", "ce:indexed-name": "Soriano V."}]}, "ref-sourcetitle": "Expert Opin Drug Saf"}}, {"ref-fulltext": "Gara N, Zhao X, Collins MT, Chong WH, Kleiner DE, Jake Liang T, et al. Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B. Aliment Pharmacol Ther. 2012;35(11):1317-25.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B"}, "refd-itemidlist": {"itemid": {"$": "84860519158", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "35", "@issue": "11"}, "pagerange": {"@first": "1317", "@last": "1325"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Gara", "ce:indexed-name": "Gara N."}, {"@seq": "2", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Zhao", "ce:indexed-name": "Zhao X."}, {"@seq": "3", "ce:initials": "M.T.", "@_fa": "true", "ce:surname": "Collins", "ce:indexed-name": "Collins M.T."}, {"@seq": "4", "ce:initials": "W.H.", "@_fa": "true", "ce:surname": "Chong", "ce:indexed-name": "Chong W.H."}, {"@seq": "5", "ce:initials": "D.E.", "@_fa": "true", "ce:surname": "Kleiner", "ce:indexed-name": "Kleiner D.E."}, {"@seq": "6", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Jake Liang", "ce:indexed-name": "Jake Liang T."}, {"@seq": "7", "ce:initials": "M.G.", "@_fa": "true", "ce:surname": "Ghany", "ce:indexed-name": "Ghany M.G."}, {"@seq": "8", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Hoofnagle", "ce:indexed-name": "Hoofnagle J.H."}]}, "ref-sourcetitle": "Aliment Pharmacol Ther"}}, {"ref-fulltext": "Jung YK, Yeon JE, Choi JH, Kim CH, Jung ES, Kim JH, et al. Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient. Gut Liver. 2010;4(3):389-93.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Fanconi's syndrome associated with prolonged adefovir dipivoxil therapy in a hepatitis B virus patient"}, "refd-itemidlist": {"itemid": {"$": "77957598950", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "4", "@issue": "3"}, "pagerange": {"@first": "389", "@last": "393"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.K.", "@_fa": "true", "ce:surname": "Jung", "ce:indexed-name": "Jung Y.K."}, {"@seq": "2", "ce:initials": "J.E.", "@_fa": "true", "ce:surname": "Yeon", "ce:indexed-name": "Yeon J.E."}, {"@seq": "3", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Choi", "ce:indexed-name": "Choi J.H."}, {"@seq": "4", "ce:initials": "C.H.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim C.H."}, {"@seq": "5", "ce:initials": "E.S.", "@_fa": "true", "ce:surname": "Jung", "ce:indexed-name": "Jung E.S."}, {"@seq": "6", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim J.H."}, {"@seq": "7", "ce:initials": "J.J.", "@_fa": "true", "ce:surname": "Park", "ce:indexed-name": "Park J.J."}, {"@seq": "8", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim J.S."}, {"@seq": "9", "ce:initials": "Y.T.", "@_fa": "true", "ce:surname": "Bak", "ce:indexed-name": "Bak Y.T."}, {"@seq": "10", "ce:initials": "K.S.", "@_fa": "true", "ce:surname": "Byun", "ce:indexed-name": "Byun K.S."}]}, "ref-sourcetitle": "Gut Liver"}}, {"ref-fulltext": "Egan BM, Zhao Y. Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals. J Clin Hypertens (Greenwich). 2013;15(3):154-61.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals"}, "refd-itemidlist": {"itemid": {"$": "84874569354", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15", "@issue": "3"}, "pagerange": {"@first": "154", "@last": "161"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.M.", "@_fa": "true", "ce:surname": "Egan", "ce:indexed-name": "Egan B.M."}, {"@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Zhao", "ce:indexed-name": "Zhao Y."}]}, "ref-sourcetitle": "J Clin Hypertens (Greenwich)"}}, {"ref-fulltext": "Heathcote EJ, Marcellin P, Buti M, Gane E, De Man RA, Krastev Z, et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology. 2011;140(1):132-43.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B"}, "refd-itemidlist": {"itemid": {"$": "78650477355", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "140", "@issue": "1"}, "pagerange": {"@first": "132", "@last": "143"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.J.", "@_fa": "true", "ce:surname": "Heathcote", "ce:indexed-name": "Heathcote E.J."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Marcellin", "ce:indexed-name": "Marcellin P."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Buti", "ce:indexed-name": "Buti M."}, {"@seq": "4", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Gane", "ce:indexed-name": "Gane E."}, {"@seq": "5", "ce:initials": "R.A.", "@_fa": "true", "ce:surname": "Man", "ce:indexed-name": "Man R.A."}, {"@seq": "6", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Krastev", "ce:indexed-name": "Krastev Z."}, {"@seq": "7", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Germanidis", "ce:indexed-name": "Germanidis G."}, {"@seq": "8", "ce:initials": "S.S.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee S.S."}, {"@seq": "9", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Flisiak", "ce:indexed-name": "Flisiak R."}, {"@seq": "10", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Kaita", "ce:indexed-name": "Kaita K."}], "et-al": null}, "ref-sourcetitle": "Gastroenterology"}}, {"ref-fulltext": "Marcellin P, Chang TT, Lim SG, Sievert W, Tong M, Arterburn S, et al. Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. Hepatology. 2008;48(3):750-8.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B"}, "refd-itemidlist": {"itemid": {"$": "51349107091", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "48", "@issue": "3"}, "pagerange": {"@first": "750", "@last": "758"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Marcellin", "ce:indexed-name": "Marcellin P."}, {"@seq": "2", "ce:initials": "T.T.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang T.T."}, {"@seq": "3", "ce:initials": "S.G.", "@_fa": "true", "ce:surname": "Lim", "ce:indexed-name": "Lim S.G."}, {"@seq": "4", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Sievert", "ce:indexed-name": "Sievert W."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Tong", "ce:indexed-name": "Tong M."}, {"@seq": "6", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Arterburn", "ce:indexed-name": "Arterburn S."}, {"@seq": "7", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Borroto-Esoda", "ce:indexed-name": "Borroto-Esoda K."}, {"@seq": "8", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Frederick", "ce:indexed-name": "Frederick D."}, {"@seq": "9", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Rousseau", "ce:indexed-name": "Rousseau F."}]}, "ref-sourcetitle": "Hepatology"}}, {"ref-fulltext": "Ha NB, Ha NB, Garcia RT, Trinh HN, Vu AA, Nguyen HA, et al. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil. Hepatology. 2009;50(3):727-34.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil"}, "refd-itemidlist": {"itemid": {"$": "70349230970", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "50", "@issue": "3"}, "pagerange": {"@first": "727", "@last": "734"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.B.", "@_fa": "true", "ce:surname": "Ha", "ce:indexed-name": "Ha N.B."}, {"@seq": "2", "ce:initials": "N.B.", "@_fa": "true", "ce:surname": "Ha", "ce:indexed-name": "Ha N.B."}, {"@seq": "3", "ce:initials": "R.T.", "@_fa": "true", "ce:surname": "Garcia", "ce:indexed-name": "Garcia R.T."}, {"@seq": "4", "ce:initials": "H.N.", "@_fa": "true", "ce:surname": "Trinh", "ce:indexed-name": "Trinh H.N."}, {"@seq": "5", "ce:initials": "A.A.", "@_fa": "true", "ce:surname": "Vu", "ce:indexed-name": "Vu A.A."}, {"@seq": "6", "ce:initials": "H.A.", "@_fa": "true", "ce:surname": "Nguyen", "ce:indexed-name": "Nguyen H.A."}, {"@seq": "7", "ce:initials": "K.K.", "@_fa": "true", "ce:surname": "Nguyen", "ce:indexed-name": "Nguyen K.K."}, {"@seq": "8", "ce:initials": "B.S.", "@_fa": "true", "ce:surname": "Levitt", "ce:indexed-name": "Levitt B.S."}, {"@seq": "9", "ce:initials": "M.H.", "@_fa": "true", "ce:surname": "Nguyen", "ce:indexed-name": "Nguyen M.H."}]}, "ref-sourcetitle": "Hepatology"}}, {"ref-fulltext": "Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J, et al. Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir. AIDS. 2009;23(6):689-96.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir"}, "refd-itemidlist": {"itemid": {"$": "64549084582", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23", "@issue": "6"}, "pagerange": {"@first": "689", "@last": "696"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Labarga", "ce:indexed-name": "Labarga P."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Barreiro", "ce:indexed-name": "Barreiro P."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Martin-Carbonero", "ce:indexed-name": "Martin-Carbonero L."}, {"@seq": "4", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Rodriguez-Novoa", "ce:indexed-name": "Rodriguez-Novoa S."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Solera", "ce:indexed-name": "Solera C."}, {"@seq": "6", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Medrano", "ce:indexed-name": "Medrano J."}, {"@seq": "7", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Rivas", "ce:indexed-name": "Rivas P."}, {"@seq": "8", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Albalater", "ce:indexed-name": "Albalater M."}, {"@seq": "9", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Blanco", "ce:indexed-name": "Blanco F."}, {"@seq": "10", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Moreno", "ce:indexed-name": "Moreno V."}], "et-al": null}, "ref-sourcetitle": "AIDS"}}, {"ref-fulltext": "Holt SG, Gracey DM, Levy MT, Mudge DW, Irish AB, Walker RG, et al. A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection. AIDS Res Ther. 2014;11:35.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection"}, "refd-itemidlist": {"itemid": {"$": "84925303179", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "35"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.G.", "@_fa": "true", "ce:surname": "Holt", "ce:indexed-name": "Holt S.G."}, {"@seq": "2", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Gracey", "ce:indexed-name": "Gracey D.M."}, {"@seq": "3", "ce:initials": "M.T.", "@_fa": "true", "ce:surname": "Levy", "ce:indexed-name": "Levy M.T."}, {"@seq": "4", "ce:initials": "D.W.", "@_fa": "true", "ce:surname": "Mudge", "ce:indexed-name": "Mudge D.W."}, {"@seq": "5", "ce:initials": "A.B.", "@_fa": "true", "ce:surname": "Irish", "ce:indexed-name": "Irish A.B."}, {"@seq": "6", "ce:initials": "R.G.", "@_fa": "true", "ce:surname": "Walker", "ce:indexed-name": "Walker R.G."}, {"@seq": "7", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Baer", "ce:indexed-name": "Baer R."}, {"@seq": "8", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Sevastos", "ce:indexed-name": "Sevastos J."}, {"@seq": "9", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Abbas", "ce:indexed-name": "Abbas R."}, {"@seq": "10", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Boyd", "ce:indexed-name": "Boyd M.A."}]}, "ref-sourcetitle": "AIDS Res Ther"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Nakhon Pathom", "@id": "60012718", "affilname": "Mahidol University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84952877007", "dc:description": "Background: There is increasing concern about the potential for nephrotoxicity in patients with chronic hepatitis B (CHB) treated long-term with nucleotide analogs. Methods: We examined renal dysfunction and its associated risk factors in patients with CHB treated with antiviral regimens containing either nucleosides or nucleotide analogs. We undertook a retrospective cohort study from 2006 to 2014 at the Hospital for Tropical Diseases, Bangkok, Thailand, and analyzed the data of 102 patients with a median follow-up time of 44.5 months (range 4-101 months). Results: Seventy-three patients were treated with an antiviral regime containing a nucleoside analog, and 29 with a regime containing a nucleotide analog. Abnormally elevated serum creatinine concentration was observed in 12 patients (11.8 %) after 8 years of treatment. Thirty one percent of patients treated with nucleotide analogs had elevated serum creatinine levels and three of these patients (10.3 %) developed nephrotoxicity. In contrast, serum creatinine concentrations were elevated in three of the 73 patients treated with a nucleoside analog (4.1 %), and none developed nephrotoxicity. The incidence of renal dysfunction by the nucleotide analog regimen was cumulative, with 11.1, 21.0, 26.5 and 47.6 % of patients affected after 2, 4, 6 and 8 years, respectively. Univariate and multivariate analysis indicated that a nucleotide analog-based regimen significantly predicted renal dysfunction (odds ratio 10.5, 95 % confidence intervals 2.6-42.4, P <0.001). Conclusion: The long-term use of nucleotide analogs increased the risk of nephrotoxicity in patients with CHB. Thus, the regular assessment of renal function is recommended for all patients with CHB, particularly those treated with a nucleotide analog.", "pubmed-id": "26651337", "prism:coverDate": "2015-12-14", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84952877007", "dc:creator": {"author": [{"ce:given-name": "Aung Myint", "preferred-name": {"ce:given-name": "Aung Myint", "ce:initials": "A.M.", "ce:surname": "Thu", "ce:indexed-name": "Thu A.M."}, "@seq": "1", "ce:initials": "A.M.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Thu", "@auid": "57003282800", "author-url": "https://api.elsevier.com/content/author/author_id/57003282800", "ce:indexed-name": "Thu A.M."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84952877007"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84952877007&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84952877007&origin=inward"}], "source-id": "21100218055", "citedby-count": "4", "prism:volume": "16", "subtype": "ar", "dc:title": "Nephrotoxicity caused by oral antiviral agents in patients with chronic hepatitis B treated in a hospital for tropical diseases in Thailand", "openaccess": "1", "prism:issn": "20506511 20506511", "publishercopyright": "\u00a9 2015 Thu et al.", "article-number": "38", "prism:issueIdentifier": "1", "subtypeDescription": "Article", "prism:publicationName": "BMC Pharmacology and Toxicology", "openaccessFlag": "true", "prism:doi": "10.1186/s40360-015-0037-6", "dc:identifier": "SCOPUS_ID:84952877007", "dc:publisher": "BioMed Central Ltd.info@biomedcentral.com"}, "idxterms": {"mainterm": [{"$": "Adenine", "@weight": "b", "@candidate": "n"}, {"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Antiviral Agents", "@weight": "b", "@candidate": "n"}, {"$": "Creatinine", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Follow-Up Studies", "@weight": "b", "@candidate": "n"}, {"$": "Guanine", "@weight": "b", "@candidate": "n"}, {"$": "Hepatitis B, Chronic", "@weight": "b", "@candidate": "n"}, {"$": "Hospitals", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Incidence", "@weight": "b", "@candidate": "n"}, {"$": "Kidney Diseases", "@weight": "b", "@candidate": "n"}, {"$": "Lamivudine", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Nephrons", "@weight": "b", "@candidate": "n"}, {"$": "Organophosphonates", "@weight": "b", "@candidate": "n"}, {"$": "Proportional Hazards Models", "@weight": "b", "@candidate": "n"}, {"$": "Retrospective Studies", "@weight": "b", "@candidate": "n"}, {"$": "Risk Assessment", "@weight": "b", "@candidate": "n"}, {"$": "Risk Factors", "@weight": "b", "@candidate": "n"}, {"$": "Tenofovir", "@weight": "b", "@candidate": "n"}, {"$": "Thailand", "@weight": "b", "@candidate": "n"}, {"$": "Thymidine", "@weight": "b", "@candidate": "n"}, {"$": "Tropical Medicine", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Antiviral agents"}, {"@_fa": "true", "$": "Chronic hepatitis B"}, {"@_fa": "true", "$": "Nephrotoxicity"}, {"@_fa": "true", "$": "Nucleoside"}, {"@_fa": "true", "$": "Nucleotide"}, {"@_fa": "true", "$": "Thailand"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Pharmacology", "@code": "3004", "@abbrev": "PHAR"}, {"@_fa": "true", "$": "Pharmacology (medical)", "@code": "2736", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Aung Myint", "preferred-name": {"ce:given-name": "Aung Myint", "ce:initials": "A.M.", "ce:surname": "Thu", "ce:indexed-name": "Thu A.M."}, "@seq": "1", "ce:initials": "A.M.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Thu", "@auid": "57003282800", "author-url": "https://api.elsevier.com/content/author/author_id/57003282800", "ce:indexed-name": "Thu A.M."}, {"ce:given-name": "Kittiyod", "preferred-name": {"ce:given-name": "Kittiyod", "ce:initials": "K.", "ce:surname": "Poovorawan", "ce:indexed-name": "Poovorawan K."}, "@seq": "2", "ce:initials": "K.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Poovorawan", "@auid": "11141160200", "author-url": "https://api.elsevier.com/content/author/author_id/11141160200", "ce:indexed-name": "Poovorawan K."}, {"ce:given-name": "Chatporn", "preferred-name": {"ce:given-name": "Chatporn", "ce:initials": "C.", "ce:surname": "Kittitrakul", "ce:indexed-name": "Kittitrakul C."}, "@seq": "3", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Kittitrakul", "@auid": "6504568189", "author-url": "https://api.elsevier.com/content/author/author_id/6504568189", "ce:indexed-name": "Kittitrakul C."}, {"ce:given-name": "Apichart", "preferred-name": {"ce:given-name": "Apichart", "ce:initials": "A.", "ce:surname": "Nontprasert", "ce:indexed-name": "Nontprasert A."}, "@seq": "4", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Nontprasert", "@auid": "6602437920", "author-url": "https://api.elsevier.com/content/author/author_id/6602437920", "ce:indexed-name": "Nontprasert A."}, {"ce:given-name": "Natthida", "preferred-name": {"ce:given-name": "Natthida", "ce:initials": "N.", "ce:surname": "Sriboonvorakul", "ce:indexed-name": "Sriboonvorakul N."}, "@seq": "5", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Sriboonvorakul", "@auid": "55919328500", "author-url": "https://api.elsevier.com/content/author/author_id/55919328500", "ce:indexed-name": "Sriboonvorakul N."}, {"ce:given-name": "Weerapong", "preferred-name": {"ce:given-name": "Weerapong", "ce:initials": "W.", "ce:surname": "Phumratanaprapin", "ce:indexed-name": "Phumratanaprapin W."}, "@seq": "6", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Phumratanaprapin", "@auid": "6602291191", "author-url": "https://api.elsevier.com/content/author/author_id/6602291191", "ce:indexed-name": "Phumratanaprapin W."}, {"ce:given-name": "Pisit", "preferred-name": {"ce:given-name": "Pisit", "ce:initials": "P.", "ce:surname": "Tangkijvanich", "ce:indexed-name": "Tangkijvanich P."}, "@seq": "7", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Tangkijvanich", "@auid": "7003646635", "author-url": "https://api.elsevier.com/content/author/author_id/7003646635", "ce:indexed-name": "Tangkijvanich P."}, {"ce:given-name": "Wattana", "preferred-name": {"ce:given-name": "Wattana", "ce:initials": "W.", "ce:surname": "Leowattana", "ce:indexed-name": "Leowattana W."}, "@seq": "8", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Leowattana", "@auid": "7006285042", "author-url": "https://api.elsevier.com/content/author/author_id/7006285042", "ce:indexed-name": "Leowattana W."}, {"ce:given-name": "Polrat", "preferred-name": {"ce:given-name": "Polrat", "ce:initials": "P.", "ce:surname": "Wilairatana", "ce:indexed-name": "Wilairatana P."}, "@seq": "9", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60012718", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718"}, "ce:surname": "Wilairatana", "@auid": "7006979896", "author-url": "https://api.elsevier.com/content/author/author_id/7006979896", "ce:indexed-name": "Wilairatana P."}]}}}